Letter: Mendelian randomization --new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply

被引：1
|
作者：
Massironi, Sara [1 ]
Vigano, Chiara [1 ]
Danese, Silvio [2 ,3 ]
机构：
[1] Fdn IRCCS San Gerardo Dei Tintori, Gastroenterol Unit, Monza, MB, Italy
[2] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[3] Univ Vita & Salute San Raffaele, Milan, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 01期
关键词：
D O I：
10.1111/apt.17552
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Massironi et al papers. To view these articles, visit and
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [21] Inflammatory bowel disease and allergic diseases: A Mendelian randomization study
    Li, Jiawei
    Wang, Lijun
    Ma, Yuqi
    Liu, Yuan
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (05)
  • [22] Migraine, inflammatory bowel disease and celiac disease: A Mendelian randomization study
    Welander, Nike Zoe
    Rukh, Gull
    Rask-Andersen, Mathias
    Harder, Aster V. E.
    van den Maagdenberg, Arn M. J. M.
    Schioth, Helgi Birgir
    Mwinyi, Jessica
    HEADACHE, 2023, 63 (05): : 642 - 651
  • [23] Circulating VEGF and inflammatory bowel disease: a bidirectional mendelian randomization
    Lin, Haishan
    Cao, Bangwei
    FRONTIERS IN GENETICS, 2024, 15
  • [24] Inflammatory bowel disease and risk for hemorrhoids: a Mendelian randomization analysis
    Wang, HanYu
    Wang, Lu
    Zeng, XiaoYu
    Zhang, ShiPeng
    Huang, Yong
    Zhang, QinXiu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [25] Inflammatory bowel disease and celiac disease: A bidirectional Mendelian randomization study
    Shi, Yue
    Feng, Sijia
    Yan, Mengdie
    Wei, Shuyan
    Yang, Kejia
    Feng, Yue
    FRONTIERS IN GENETICS, 2022, 13
  • [26] Inflammatory Bowel Disease and Skin Cancer: A Two-Sample Mendelian Randomization Analysis
    Li, Aoshuang
    Yu, Mengting
    Wu, Kaiwen
    Liu, Lei
    Sun, Xiaobin
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (03) : 91 - 99
  • [27] Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply
    Christensen, B.
    Gibson, P. R.
    Rubin, D. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1423 - 1424
  • [28] Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply
    Vasudevan, Abhinav
    Con, Danny
    van Langenberg, Daniel R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (08) : 1011 - 1011
  • [29] Letter: irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease - authors' reply
    Diederen, K.
    Hoekman, D. R.
    Benninga, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (03) : 309 - 310
  • [30] Letter: pancreatic involvement in inflammatory bowel disease
    Dai, Cong
    Huang, Yu-hong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 370 - 370
12345